FIRST-IN-CLASS PIPELINE
new discovery targets in the nuclear receptor family
Orphagen has unique insight into additional, largely unexplored, NR targets based on its exploratory research.
These include:
- Potent antagonists to an orphan receptor critical for CNS and retinal development
- Assay expertise for orphan targets with strong validation in autoimmunity, hematology, and oncology
